Late outcomes of colorectal cancer treatment: A FECS-EUROCARE study

Journal of Cancer Survivorship

Volumn 1, Issue 4, 2007, Pages 247-254

  Gatta, Gemma ^a   Ciccolallo, Laura ^a   Faivre, Jean ^b   Bouvier, Anne Marie ^b   Berrino, Franco ^a   Gerard, Jean Pierre ^c  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITÉ DE BOURGOGNE   (France)

^c CENTRE ANTOINE LACASSAGNE   (France)

Author keywords

Bowel incontinence; Colorectal cancer; ECOG performance status; Late outcomes; Long term survivors; Population based study; Stoma

Indexed keywords

ARTICLE; COLORECTAL TUMOR; FECES INCONTINENCE; FEMALE; FRANCE; GASTROINTESTINAL DISEASE; GENERAL PRACTITIONER; HUMAN; INCIDENCE; ITALY; MALE; MORTALITY; QUESTIONNAIRE; RECURRENT DISEASE; REGISTER; SURVIVAL; SURVIVOR; TREATMENT OUTCOME;

COLORECTAL NEOPLASMS; FECAL INCONTINENCE; FEMALE; FRANCE; GASTROINTESTINAL DISEASES; HUMANS; INCIDENCE; ITALY; MALE; PHYSICIANS, FAMILY; QUESTIONNAIRES; RECURRENCE; REGISTRIES; SURVIVAL ANALYSIS; SURVIVORS; TREATMENT OUTCOME;

EID: 36749017493     PISSN: 19322259     EISSN: 19322267     Source Type: Journal    
DOI: 10.1007/s11764-007-0030-1     Document Type: Article

References (26)

1. Boyle P, Ferlay J. Cancer incidence and mortality in Europe, 2004. Ann Oncol. 2005;16(3):481-8.
2. Roazzi P, Capocaccia R, Santaquilani M, Carrani E. Electronic availability of EUROCARE-3 data: a tool for further analysis. Ann Oncol. 2003;14(Suppl 5):v150-5.
3. Faivre-Finn C, Bouvier-Benhamiche AM, Phelip JM, Manfredi S, Dancourt V, Faivre J. Colon cancer in France: evidence for improvement in management and survival. Gut. 2002;51(1):60-4.
4. Micheli A, Mugno E, Krogh V, Quinn MJ, Coleman MP, Hakulinen T, Gatta G, Berrino F, Capocaccia R, and the EUROPREVAL Working Group. Cancer prevalence in European registry areas. Ann Oncol. 2002;13:840-65.
5. Oken MM, Creech RH, Tormey DC, Horton J, Davis,TE, McFadden ET, Carbone PP. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5:649-55.
6. Gatta G, Capocaccia R, Sant M, Bell CMJ, Coebergh JWW, Damhuis RAM, et al. Understanding variations in colorectal cancer survival in Europe: a EUROCARE high-resolution study. Gut. 2000;47:533-8.
7. World Health Organisation. International Classification of Diseases, 1975, 9th edition. Geneva: WHO; 1997.
8. P. Hermanek, LH Sobin (eds). TNM Classification of Malignant Tumours, Fourth Edition, 2nd Revision 1992. UICC, International Union Against Cancer, Springer.
9. Sprangers MA, te Velde A, Aaronson NK. The construction and testing of the EORTC colorectal cancer-specific quality of life questionnaire module (QLQ-CR38). European Organization for Research and Treatment of Cancer Study Group on Quality of Life. Eur J Cancer. 1999;35(2):238-47.
10. StataCorp. Stata Statistical Software: Release 7.0. College Station, TX: Stata Corporation; 2001.
11. Trentham-Dietz A, et al. Health-related quality of life in female long-term colorectal cancer survivors. The Oncologist. 2003;8:342-9.
12. Ramsey DS, et al. Quality of life in survivors of colorectal carcinoma. Cancer. 2000;88(6):1294-303.
13. Ramsey DS, et al. Quality of life in long term survivors of colorectal cancer. Am J Gastroenterol. 2002;97(5):1228-34.
14. Kirwan WO, O'Riordain MG, Waldron R. Declining indications for abdominoperineal resections. Br J Surg. 1989;76:1061-3.
15. Finn-Faivre C, Maurel J, Benhamiche AM, Herbert C, Mitry E, Launoy G, Faivre J. Evidence of improving survival of patients with rectal cancer in France: a population based study. Gut. 1999;44:377-81.
16. Pollack J, Holm T, Cedermark B, Holmstrom B, Mellgren A. Long-term effect of preoperative radiation therapy on anorectal function. Dis Colon Rectum. 2006;49(3):345-52.
17. Lundby L, Krogh K, Jensen VJ, Gandrup P, Qvist N, Overgaard J, Laurberg S. Long-term anorectal dysfunction after postoperative radiotherapy for rectal cancer. Dis Colon Rectum. 2005;48(7):1343-9.
18. Manfredi S, Bouvier AM, Lepage C, Hatem C, Dancourt V, Faivre J. Incidence and patterns of recurrence after resection for cure of colonic cancer in a well defined population. Br J Surg. 2006;93(9):1115-22.
19. Gatta G, Capocaccia R, Berrino F, Ruzza M, Contiero P, and the EUROPREVAL Working Group. Colon cancer prevalence and estimation of differing care needs of colon cancer patients. Ann Oncol. 2004;15(7):1136-42.
20. Yabroff KR, Lawrence WF, Clauser S, Davis WW, Brown ML. Burden of illness in cancer survivors: findings from a population-based national sample. J Natl Cancer Inst. 2004;96(17):1322-30.
21. McCredie M, Macfarlane GJ, Bell J, Coates M. Second primary cancers after cancer of the colon and rectum in New South Wales, Australia, 1972-1991. Cancer Epidemiol Biomarkers Prev. 1997;6(3):155-60.
22. Hoar SK, Wilson J, Blot WJ, McLaughlin JK, Winn DM, Kantor AF. Second cancer following cancer of the digestive system in Connecticut, 1935-82. Natl Cancer Inst Monogr. 1985;68:49-82.
23. Enblad P, Adami HO, Glimelius B, Krusemo U, Påhlman L. The risk of subsequent primary malignant diseases after cancers of the colon and rectum. Cancer. 1990;65:2091-100.
24. Burt RW. Familial risk and colorectal cancer. Gastroenterol Clin North Am. 1996;25(4):793-803.
25. Renehan AG, Egger M, Saunders MP, O'Dwyer ST. Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials. BMJ. 2002;324(7341):813.
26. NIH Consensus Conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA. 1990;264:1444-50.